Bibliografía
1. Bray F et al. Globocan Ca Cancer J Clin 2018;68:394–424
2. Marrelli D, Pedrazzani C, Morgagni D, de Manzoni G, Pacelli F, Coniglio A, et al. Changing clinical and pathological features of gastric cancer over time. Bri J Surg. 2011;98:1273–83.
3. Slagter AE, Jansen EPM, van Laarhoven HWM, et al. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. BMC Cancer. 2018;18(1):877. Published 2018 Sep 10. doi:10.1186/s12885-018-4770-2
4. Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value. World J Gastroenterol 2014; 20(19): 5679-5684. DOI: https://dx.doi.org/10.3748/wjg.v20.i19.5679
5. Marano L, D'Ignazio A, Cammillini F, et al. Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: old problems and new perspectives. Transl Gastroenterol Hepatol. 2019;4:22. Published 2019 Apr 3. doi:10.21037/tgh.2019.03.09
6. In, H., Solsky, I., Palis, B. et al. Ann Surg Oncol (2017) 24: 3683. https://doi.org/10.1245/s10434-017-6078-x
7. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 64:31-49, 1965.
8. U, B., El Hajj, N., Sittler, S., Lammert, N., Barnes, R., Meloni-Ehrig, A.. Gastric cancer: Classification, histology and application of molecular pathology. Journal of Gastrointestinal Oncology, North America, 3, jul. 2012.
9. Lauwers GY, Carneiro F, Graham DY, Curado M-P, Franceschi S, Montgomery E, Tatematsu M, Hattori T: Gastric Carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system, 4th ed. IARC Press: Lyon; 2010, pp. 48–58
10. Mariette, C. Carneiro, F., Grabsch, H.I. et al. Gastric Cancer (2019) 22: 1. https://doi.org/10.1007/s10120-018-0868-0
11. Serban D, Branescu C, et al. Complex histopathological and surgical aspects in a case of giant malignant gastric perforation. Journal of Medicine and Life Vol. 9, Issue 2, April-June 2016, pp.216-219
12. Zu H, Wang H, Li C, Xue Y. Clinicopathologic characteristics and prognostic value of various histological types in advanced gastric cancer. Int J Clin Exp Pathol. 2014;7(9):5692–5700. Published 2014 Aug 15.
13. Qiu et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. Journal of Translational Medicine 2013, 11:58 http://www.translational-medicine.com/content/11/1/58
14. Cunningham D, M.D., William H. Allum, M.D., Sally P. Stenning et al. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. The New England Journal of Medicine. 2006 Jul 6;355(1):11-20.
15. Al-Batran SE, Hofh einz RD, Pauligk C et al. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fl uorouracil, and leucovorin versus epirubicin, cisplatin, and fl uorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol 2016; 17: 1697–708.
16. As Nie RC, Yuan SQ, Li YF, Chen YM, Chen XJ, Zhu BY, Xu LP, Zhou ZW, Chen S, Chen YB. Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis. J Cancer 2017; 8(17):3396-3404. doi:10.7150/jca.21017. Available from http://www.jcancer.org/v08p3396.htm
17. Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 Available from: URL: http://www.wjgnet. com/1007-9327/full/v21/i40/11428.htm DOI: http://dx.doi. org/10.3748/wjg.v21.i40.11428
18. C. Mariette, F. Carneiro, . I. Grabsch, et al. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer (2019) 22:1–9 https://doi.org/10.1007/s10120-018-0868-0
19. Tang X, Zhang J, Che X, Lan Z, Chen Y, Wang C. The clinicopathological features and long-term survival outcomes of mucinous gastric carcinoma: a consecutive series of 244 cases from a single institute. J Gastrointest Surg. 2016; 20:693-699
20. Bass, A. J., Thorsson, V., Shmulevich, I., et al, Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513(7517), 202-209. DOI: 10.1038/nature13480
21. IARC Publications. Digestive System Tumours. World Health Organization Classification of Tumours. 5th Edition. Chapter 3. Tumours of the stomach.
22. Birkman EM, Mansuri N, Kurki S, et al. Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Virchows Arch. 2018;472(3):369-382. doi:10.1007/s00428-017-2240-x